Home > Healthcare > Medical Devices > Surgical Devices > endoscopic vessel harvesting systems market
Get a free sample of Endoscopic Vessel Harvesting Systems Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Endoscopic Vessel Harvesting Systems Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The latest technological advancements in EVH systems represent a significant step forward in improving the efficiency, precision, and safety of the vessel harvesting process in cardiac surgery. These advancements ultimately translate into better outcomes for patients, with reduced postoperative complications and faster recovery times.
The market size of endoscopic vessel harvesting systems crossed USD 549.7 million in 2023 and is set to reach USD 789.6 million by 2032, propelled by the increasing prevalence of cardiovascular diseases.
The EVH systems product type segment in the market held a revenue of USD 302.8 million in 2023, driven by the clinical need for minimally invasive techniques in cardiac surgery.
North America endoscopic vessel harvesting systems industry accounted for USD 222.7 million in revenue in 2023, led by a significant burden of cardiovascular diseases (CVDs).
Cardio Precision Ltd., Getinge AB, LivaNova PLC, Medical Instruments Spa, Saphena Medical Inc., Sorin Group, Terumo Corporation among others.